215 related articles for article (PubMed ID: 11691785)
1. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
4. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
5. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma.
Nagao K; Yamaguchi S; Matsuyama H; Korenaga Y; Hirata H; Yoshihiro S; Fukunaga K; Oba K; Naito K
Cancer Genet Cytogenet; 2005 Jul; 160(1):43-8. PubMed ID: 15949569
[TBL] [Abstract][Full Text] [Related]
8. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 3 in renal cell carcinoma.
Renshaw AA; Fletcher JA
Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.
Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C
Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
Klatte T; Pantuck AJ; Said JW; Seligson DB; Rao NP; LaRochelle JC; Shuch B; Zisman A; Kabbinavar FF; Belldegrun AS
Clin Cancer Res; 2009 Feb; 15(4):1162-9. PubMed ID: 19228721
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of chromosome 5q correlate with morphologic features of better prognosis in clear cell renal carcinomas.
Podolski J; Huzarski T; Byrski T; Tołoczko A; Wrzecion S; Sikorski A; Mahoy P; Huebner K; Rabbitts P; Lubiński J
Pol J Pathol; 1995; 46(3):163-6. PubMed ID: 7496735
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma.
Moch H; Presti JC; Sauter G; Buchholz N; Jordan P; Mihatsch MJ; Waldman FM
Cancer Res; 1996 Jan; 56(1):27-30. PubMed ID: 8548768
[TBL] [Abstract][Full Text] [Related]
14. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
16. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
18. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
Lau LC; Tan PH; Chong TW; Foo KT; Yip S
Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
[TBL] [Abstract][Full Text] [Related]
20. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
